Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Small (Weinheim an Der Bergstrasse, Germany)|November 30, 2024
Resurrecting p53 by an Artificial Nano-Protein for Potent Photodynamic Retinoblastoma TherapySiqi Yan, Wenguang Yang, Weiming You, et al.Small (Weinheim an Der Bergstrasse, Germany)|April 19, 2021
De Novo Nano-Erythrocyte Structurally Braced by Biomimetic Au(I)-peptide Skeleton for MDM2/MDMX Predation toward Augmented Pulmonary Adenocarcinoma ImmunotherapyXiaoqiang Zheng, Jin Yan, Weiming You, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 3, 2024
Rewiring chaperone-mediated autophagy in cancer by a prion-like chemical inducer of proximity to counteract adaptive immune resistanceJin Yan, Dan Liu, Jingmei Wang, et al.Journal of Biomedical Nanotechnology|August 8, 2019
Modulating Protein-Protein Interactions In Vivo via Peptide-Lanthanide-Derived Nanoparticles for Hazard-Free Cancer TherapyGuang Yang, Jun Zhang, Jin Yan, et al.International Journal of Biological Sciences|October 13, 2025
Bringing p53 Back: A Prion-Powered Attack on RetinoblastomaYuyan Ma, Siqi Yan, Weiming You, et al.Frontiers in Immunology|September 15, 2025
Disrupting β-Catenin/BCL9 interaction with a peptide prodrug boosts immunotherapy in colorectal cancerPeili Wang, Xiao Shang, Jinmei Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2007
No association between TGFBR1*6A and lung cancerWeiming You, Zeyi Liu, Jun Zhao, et al.Nanotechnology|November 22, 2019
Targeted disruption of the BCL9/β-catenin interaction by endosomal-escapable nanoparticles functionalized with an E-cadherin-derived peptideGuang Yang, Jun Zhang, Weiming You, et al.Materials Today. Bio|August 5, 2025
Dual-targeted N-PMIplus@CA nanoplatform for concurrent MDM2 and β-catenin inhibition in p53 wild-type lung adenocarcinomaNi Zhao, Weiming You, Xiaoqiang Zheng, et al.Theranostics|March 10, 2022
Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapyWangxiao He, Zhang Zhang, Wenguang Yang, et al.Pageof 4